2025
Addressing Peri-Device Leaks in Next-Generation Transcatheter Left Atrial Appendage Occluders: An Open Question
Roshanfar M, Jang S, Sinusas A, Wong S, Mosadegh B. Addressing Peri-Device Leaks in Next-Generation Transcatheter Left Atrial Appendage Occluders: An Open Question. Surgeries 2025, 6: 15. DOI: 10.3390/surgeries6010015.Peer-Reviewed Original ResearchPeri-device leakLeft atrial appendageFDA-approved devicesRisk of thrombo-embolic eventsNon-valvular atrial fibrillationLeft atrial appendage anatomyLong-term anticoagulationPercutaneous LAA occlusionCHA2DS2-VASc scoreThrombo-embolic eventsIncreased risk of strokeRisk of strokeCircular cross-sectionLeft atrial appendage occluderSystemic embolismAnticoagulant therapyLAA occlusionObservational registryCHA2DS2-VAScNon-pharmacological alternativeAdverse eventsAtrial fibrillationAtrial appendageClinical dataIncreased risk
2020
Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation
Lee V, Jairam V, Yu JB, Park HS. Nationwide patterns of hemorrhagic stroke among patients hospitalized with brain metastases: influence of primary cancer diagnosis and anticoagulation. Scientific Reports 2020, 10: 10084. PMID: 32572113, PMCID: PMC7308286, DOI: 10.1038/s41598-020-67316-8.Peer-Reviewed Original ResearchConceptsBrain metastasesLong-term anticoagulationIntracerebral hemorrhageKidney cancerHigh riskUtilization Project Nationwide Inpatient SampleDiagnosis of ICHHospital-related characteristicsRisks of anticoagulationPrimary cancer diagnosisMultivariable logistic regressionNationwide Inpatient SampleLonger lengthDiagnosis of melanomaMann-Whitney UHemorrhagic strokeNeurologic dysfunctionConcurrent diagnosisSignificant morbiditySecondary diagnosisInpatient SampleBaseline differencesDecreased qualityAnticoagulationHealthcare costs
2013
Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
Moeckel GW, Luciano RL, Brewster UC. Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin. Clinical Kidney Journal 2013, 6: 507-509. PMID: 26120444, PMCID: PMC4438392, DOI: 10.1093/ckj/sft076.Peer-Reviewed Case Reports and Technical NotesAcute kidney injuryTubular injuryIgA nephropathyMild IgA nephropathyAcute tubular injuryLong-term anticoagulationDirect thrombin inhibitorKidney injurySevere hematuriaRenal biopsyGlomerular pathologyDabigatranPatientsThrombin inhibitorsNephropathyInjuryWarfarinAnticoagulationHematuriaAspirinBiopsyPathology
2005
Single Institution Experience with Inferior Vena Cava Filters.
Bhalla N, Bulgaru A, Church L, Kapur D, Lustberg H, Slater D, Dhami M. Single Institution Experience with Inferior Vena Cava Filters. Blood 2005, 106: 914. DOI: 10.1182/blood.v106.11.914.914.Peer-Reviewed Original ResearchDeep venous thrombosisRetrievable IVC filtersRecurrent deep venous thrombosisInferior vena cava filterSymptomatic pulmonary embolismPulmonary embolismPermanent IVC filtersIVC filtersVena cava filtersPermanent filtersClot burdenVenous thromboembolismCava filtersSymptomatic deep venous thrombosisTransient low-grade feverPoor pulmonary reserveRetrieval of filtersLow-grade feverRecurrent venous thromboembolismIncidence of complicationsIVC filter insertionLong-term anticoagulationSingle institution experienceAdverse clinical consequencesChest CT scan
2000
Surgical management of giant descending aortic thrombus detected by transesophageal echocardiography
Modi B, Longo M, Kopf G, Elefteriades J. Surgical management of giant descending aortic thrombus detected by transesophageal echocardiography. International Journal Of Angiology 2000, 9: 243-245. PMID: 11062316, DOI: 10.1007/bf01623903.Peer-Reviewed Original ResearchSurgical management of giant descending aortic thrombus detected by transesophageal echocardiography
Modi B, Longo M, Kopf G, Elefteriades J. Surgical management of giant descending aortic thrombus detected by transesophageal echocardiography. International Journal Of Angiology 2000, 243-245. DOI: 10.1055/s-0031-1276264.Peer-Reviewed Original Research
1999
Low molecular weight heparin: An evaluation of current and potential clinical utility in surgery
Davies R, Coady M, Hammond G, Elefteriades J, Gusberg R. Low molecular weight heparin: An evaluation of current and potential clinical utility in surgery. International Journal Of Angiology 1999, 8: 203-215. PMID: 10559462, DOI: 10.1007/bf01616318.Peer-Reviewed Original ResearchLow molecular weight heparinRole of LMWHUse of LMWHMechanical cardiac support devicesProphylaxis of DVTLong-term anticoagulationMolecular weight heparinCardiac support deviceLevel of evidenceVascular graft patencyPotential clinical utilityFrench language articlesFurther studiesStrength of evidenceLMWH administrationTransplant atherosclerosisLMWH therapySuch prophylaxisSurgical patientsWarfarin therapyGraft patencyVenous thrombosisMechanical heart valvesWeight heparinCurrent therapiesLow molecular weight heparin: An evaluation of current and potential clinical utility in surgery
Davies R, Coady M, Hammond G, Elefteriades J, Gusberg R. Low molecular weight heparin: An evaluation of current and potential clinical utility in surgery. International Journal Of Angiology 1999, 203-215. DOI: 10.1055/s-0031-1276200.Peer-Reviewed Original ResearchLow molecular weight heparinRole of LMWHUse of LMWHMechanical cardiac support devicesProphylaxis of DVTLong-term anticoagulationMolecular weight heparinCardiac support deviceLevel of evidenceVascular graft patencyPotential clinical utilityFrench language articlesFurther studiesStrength of evidenceLMWH administrationTransplant atherosclerosisLMWH therapySuch prophylaxisSurgical patientsWarfarin therapyGraft patencyVenous thrombosisMechanical heart valvesWeight heparinCurrent therapies
1993
Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi
Manning W, Silverman D, Gordon S, Krumholz H, Douglas P. Cardioversion from Atrial Fibrillation without Prolonged Anticoagulation with Use of Transesophageal Echocardiography to Exclude the Presence of Atrial Thrombi. New England Journal Of Medicine 1993, 328: 750-755. PMID: 8437595, DOI: 10.1056/nejm199303183281102.Peer-Reviewed Original ResearchConceptsAtrial thrombusLong-term anticoagulationAtrial fibrillationTransesophageal echocardiographyOral anticoagulationEarly cardioversionTransthoracic echocardiographyLong-term oral anticoagulationConventional noninvasive techniquesOral anticoagulation therapyShort-term anticoagulationPresence of thrombusAnticoagulation therapyEmbolic eventsQualifying patientsConsecutive patientsProlonged anticoagulationSuccessful cardioversionSinus rhythmAnticoagulationCardioversionEchocardiographyPatientsThrombusFibrillation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply